About: Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 20 June 2014

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2014 (uk) article scientifique publié en 2014 (fr) im Juni 2014 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 20 June 2014 (en) artículu científicu espublizáu en xunu de 2014 (ast)
publication date	wds:Q57316342-F3D3B777-16CD-47FF-BDA6-B8DB98874E31
publication date	2014-06-20 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57316342-F27229DC-E67D-4514-95AC-5F349D0D264D
language of work or name	English
exact match	wds:Q57316342-7BE4A108-8A02-4DE0-9FEF-C98DAA2E6870
exact match	https://scigraph.springernature.com/pub.10.1038/ijo.2014.105
cites work	wds:Q57316342-025FB96E-89F0-4912-8135-C4C3229C441E wds:Q57316342-08F8F76B-A4EA-4EB8-B193-8CA854C79456 wds:Q57316342-1A5610CD-C797-480F-9F79-9E80CEBBE92F wds:Q57316342-2946A41C-E5AE-4524-ADC7-A1BC21F3205A wds:Q57316342-2E0F298D-1746-4C94-9652-6E727F63FDDB wds:Q57316342-3CE49CFB-A875-4823-B238-D8F4A3DB6F68 wds:Q57316342-40570A3C-959F-479C-B7E4-F864F2C804AC wds:Q57316342-411E03B4-FEE1-49E2-9EDA-2384ED24B563 wds:Q57316342-47F77417-23B0-4E81-AA10-D3275509A750 wds:Q57316342-5D2EF9B6-45DA-4791-9BBC-85D80747E893 wds:Q57316342-6EF5CDAE-726F-4C7D-A3C9-FD4CE119242B wds:Q57316342-80487A42-1CDB-4137-BDF3-26529F0E65DD wds:Q57316342-87247215-02E2-42AC-9DC6-BCC4ABBFACB8 wds:Q57316342-907B0756-A8AE-421A-BB52-8E8E628E3D91 wds:Q57316342-9915A6CE-FEAF-4568-A079-696DC5020489 wds:Q57316342-9E0F128A-4B22-4E46-A7C2-6C907F3ACC29 wds:Q57316342-A28A584E-F843-45D1-885F-D9AEACEBFBDD wds:Q57316342-A62DDCF1-8D3F-4D56-A826-BD2106C92E96 wds:Q57316342-B0FD4BA3-0535-4C9D-9008-B35593EF2F2C wds:Q57316342-B62B90CF-C560-4BA5-8871-9599E8427AEF wds:Q57316342-BA03914F-FCC4-41EA-B38C-935AEE9D6E5B wds:Q57316342-C249E4CF-8A51-4DC9-BE76-5290E45B69C0 wds:Q57316342-CAD8BE02-35D5-4854-A75D-6FAF669AC7B0 wds:Q57316342-CD04532F-9AC6-47F0-8E89-5D0434B9C56C wds:Q57316342-E0328001-06A4-4356-B799-19A1953910A6
cites work	Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes. The link between abdominal obesity, metabolic syndrome and cardiovascular disease Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Review: a gentle introduction to imputation of missing values Biological, clinical and population relevance of 95 loci for blood lipids Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue The Biochemical, Clinical, and Genetic Features of Type III Hyperlipoproteinemia Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158 --> Cys) homozygotes is associated with hyperinsulinemia. Apolipoprotein E: far more than a lipid transport protein Association of apolipoprotein E genotypes with lipid levels and coronary risk ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study Dysbetalipoproteinaemia--clinical and pathophysiological features Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study. Second manifestations of ARTerial disease (SMART) study: rationale and design Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III Associations between apolipoprotein E genotype, diet, body mass index, and serum lipids in Lithuanian adult population Pathogenesis and management of the dyslipidemia of the metabolic syndrome The APOE locus and the pharmacogenetics of lipid response
author name string	wds:Q57316342-84898E1B-8E2D-4B04-A060-CFA169E803D6 wds:Q57316342-A1032F4C-6EC2-436B-8A2E-74E887B13BC5 wds:Q57316342-BAE37BA6-D300-466C-9EC4-31EF0EF284B8 wds:Q57316342-CF512BAF-6773-43A2-A855-F979B7E4FD9E
author name string	Y van der Graaf J Westerink SMART study group C Koopal
rdfs:label	Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease (en) Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease (nl)
skos:prefLabel	Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease (en) Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease (nl)
name	Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease (en) Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease (nl)
author	wds:Q57316342-10C2AC2B-213C-4E40-B392-91F01C1288E3 wds:Q57316342-70F6E9E9-4B54-448A-8E95-7F2D2999F2A5
author	Folkert Asselbergs Frank L Visseren
title	wds:Q57316342-31B9F3B8-C947-41D3-B478-2271491F96C7
title	Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease (en)
page(s)	wds:Q57316342-52092266-4471-4852-910C-CB3D03E13768
page(s)	265-269
instance of	wds:Q57316342-CA0844A2-43F8-4045-B62A-E3D140E4EEC1
instance of	scholarly article
main subject	wds:Q57316342-46E4E366-AE5F-4F7C-97B2-AC7391888EAD
main subject	vascular disease
PubMed ID	wds:Q57316342-F4B78ADA-C9E0-4EA7-81C8-7290BBEE3DE7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24946908
PubMed ID	24946908
published in	wds:Q57316342-AB919155-B4CE-41D3-956C-0A5CD20C1EF8
published in	International Journal of Obesity
issue	wds:Q57316342-7DDE208A-9619-4343-A8AE-4222934408B0
volume	wds:Q57316342-23A43318-52FC-4402-AF0B-2C9035BC0E2D
issue	2
volume	39
DOI	wds:Q57316342-F6EFAB50-8FC1-4F47-91D6-AD454C3C42F7
DOI	http://dx.doi.org/10.1038/IJO.2014.105

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software